10.11.2015 • NewsCEOBoardChemical

DuPont Names Breen as Permanent CEO

As expected, DuPont has appointed interim CEO Edward Breen permanently to the top job. Following the abrupt departure of former CEO Ellen Kullman in mid-October, Breen was also named chairman of the company’s board of directors, which he joined in February, and charged with the task of finding Kullman’s successor. The turnaround specialist is believed to have the support of activist investor Nelson Peltz, who is also the company’s biggest shareholder.

As head of Tyco from 2002 to 2012, Breen’s legacy is the breakup of the scandal-ridden US conglomerate into six standalone companies, His appointment is likely to be a sign that DuPont’s board of directors is considering more radical steps than it did previously, one analyst commented. Over the past week, the US chemical giant has announced the consolidation of several polymers businesses and confirmed it is talking to rivals about its agriculture business, with media reports pointing to Syngenta or Dow Chemical.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.